MktsMarkets

Boston Scientific Corporation
NYSE: BSXKey statistics
BSX News
Stories mentioning BSX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,203,000 | 5,285,000 | 5,065,000 | 5,061,000 | 4,663,000 | 4,562,000 | 4,209,000 | 4,120,000 |
| Cost of Goods Sold | 1,590,000 | 1,608,000 | 1,523,000 | 1,637,000 | 1,453,000 | 1,466,000 | 1,312,000 | 1,270,000 |
| Gross Profit | 3,614,000 | 3,678,000 | 3,542,000 | 3,424,000 | 3,210,000 | 3,095,000 | 2,897,000 | 2,850,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 1,781,000 | 1,833,000 | 1,741,000 | 1,716,000 | 1,597,000 | 1,612,000 | 1,562,000 | 1,446,000 |
| Total Operating Expenses | 2,513,000 | 2,854,000 | 2,494,000 | 2,605,000 | 2,288,000 | 2,420,000 | 2,164,000 | 2,330,000 |
| Operating Income (Loss) | 1,101,000 | 825,000 | 1,048,000 | 819,000 | 921,000 | 675,000 | 733,000 | 520,000 |
| Interest Income | ||||||||
| Interest Expense | 90,000 | 90,000 | 87,000 | 90,000 | 82,000 | 80,000 | 79,000 | 77,000 |
| Other Expense | 61,000 | (124,000) | (110,000) | 122,000 | (116,000) | (89,000) | (65,000) | (100,000) |
| Pretax Income | 1,162,000 | 700,000 | 939,000 | 941,000 | 805,000 | 585,000 | 669,000 | 420,000 |
| Tax Provision | (176,000) | 31,000 | 183,000 | 146,000 | 133,000 | 23,000 | 200,000 | 98,000 |
| Net Income (Loss) | ||||||||
| Earnings Per Share (Basic) | 0.90 | 0.00 | 0.51 | 0.54 | 0.46 | 0.00 | 0.32 | 0.22 |
| Earnings Per Share (Diluted) | 0.90 | 0.00 | 0.51 | 0.53 | 0.45 | 0.00 | 0.32 | 0.22 |
| Weighted Average Shares Outstanding (Basic) | 1,484,900 | 1,480,400 | 1,481,700 | 1,479,900 | 1,477,200 | 1,471,500 | 1,472,700 | 1,470,600 |
| Weighted Average Shares Outstanding (Diluted) | 1,495,000 | 1,494,500 | 1,495,500 | 1,493,500 | 1,493,100 | 1,485,900 | 1,487,400 | 1,484,200 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BSX
Boston Scientific Corporation (NYSE: BSX) is a stock listed on the New York Stock Exchange under the ticker symbol BSX. It last traded at $44.34 (Nov 13, 2026, 4:00 PM ET), up 0.3% on the day. That gives Boston Scientific a market capitalisation of $64.3B and a price-to-earnings ratio of 18.4.
Over the past 52 weeks BSX has traded between $39.57 and $105.65.
Revenue for the quarter ended Mar 31, 2026 was $5.2B. Revenue was up 11.6% from $4.7B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $5.2B | — |
| Dec 31, 2025 | $5.3B | — |
| Sep 30, 2025 | $5.1B | — |
| Jun 30, 2025 | $5.1B | — |
From Boston Scientific’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…